Simply Solventless Concentrates Past Earnings Performance
Past criteria checks 1/6
Simply Solventless Concentrates has been growing earnings at an average annual rate of 95.1%, while the Pharmaceuticals industry saw earnings growing at 43.4% annually. Revenues have been growing at an average rate of 54.8% per year. Simply Solventless Concentrates's return on equity is 28.5%, and it has net margins of 11%.
Key information
95.1%
Earnings growth rate
98.8%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | 54.8% |
| Return on equity | 28.5% |
| Net Margin | 11.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Simply Solventless Concentrates makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 11 | 1 | 3 | 0 |
| 30 Jun 24 | 8 | 1 | 2 | 0 |
| 31 Mar 24 | 7 | 1 | 2 | 0 |
| 31 Dec 23 | 6 | 1 | 1 | 0 |
| 30 Sep 23 | 7 | 2 | 1 | 0 |
| 30 Jun 23 | 6 | 2 | 1 | 0 |
| 31 Mar 23 | 4 | 0 | 1 | 0 |
| 31 Dec 22 | 3 | -2 | 1 | 0 |
| 31 Dec 21 | 1 | -2 | 2 | 0 |
Quality Earnings: HASH has a high level of non-cash earnings.
Growing Profit Margin: HASH's current net profit margins (11%) are lower than last year (33.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if HASH's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: HASH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: HASH had negative earnings growth (-44%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-44%).
Return on Equity
High ROE: HASH's Return on Equity (28.5%) is considered high.